Sales & Marketing News | pharmaphorum

News

FDA plan will cut testing requirements for biosimilars

The FDA has proposed a radical change to the regulatory requirements for bringing biosimilar medicines to market as a way to cut US drug prices.

News

Specialty meds lift GSK's outlook in Walmsley's swan song

Emma Walmsley's last set of financial results as GSK's chief executive has gone swimmingly, allowing the company to raise its 2025 forecasts.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

News

Novartis' new drugs outweigh Entresto decline in Q3

Now feeling the impact of generic competition on its top product Entresto in the US, Novartis is still looking for pipeline-building deals, says CEO.

News

Organon CEO resigns over 'improper' contraceptive sales

Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.

FDA plan will cut testing requirements for biosimilars

Specialty meds lift GSK's outlook in Walmsley's swan song

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Texas sues J&J, Kenvue over Tylenol autism claim

Novartis' new drugs outweigh Entresto decline in Q3

Organon CEO resigns over 'improper' contraceptive sales

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks